课题基金 / 基金详情

HUMAN C1 INHIBITOR IN HEREDITARY AND ACQUIRED ANGIOEDEMA

HUMAN C1 INHIBITOR IN HEREDITARY AND ACQUIRED ANGIOEDEMA
人类 C1 抑制剂治疗遗传性和获得性血管性水肿
批准号:
6441971
负责人:
RAIF SALIM GEHA
金额:
$2.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2001-11-30

项目摘要

项目成果

RAIF SALIM GEHA的其他基金

相似基金

相关文献

中文摘要
翻译
C1 INH-IMMUNO治疗遗传性血管性水肿(HAE)的开放标签研究。HAE是一种急性、复发性、界限明确、无凹陷性的上皮下水肿,主要累及四肢、面部、腹部和喉部的疾病。HAE的特点是功能性C1抑制剂明显减少。本研究试图通过给予C1抑制剂来控制HAE的症状。C1抑制剂是治疗HAE发作的有效疗法,无不良反应。
英文摘要
Open-label study of C1 INH-IMMUNO in the treatment of Hereditary Angioedema (HAE). HAE is a condition in which acute, recurrent episodes of well circumscribed, nonpitting, subepithelial edema primarily involving the extremities, face, abdomen, and larynx. HAE is characterized by a marked decrease in functional C1 inhibitor. This study attempts to control the symptoms of HAE by administering C1 inhibitor. The C1 inhibitor is effective therapy for the treatment of attacks of HAE with no adverse reactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis
  • 批准号:
    10638821
  • 项目类别:
  • 资助金额:
    $80.01万
  • 财政年份:
    2023
  • 负责人:
    RAIF SALIM GEHA
  • 依托单位:
Molecular and cellular mechanisms in food anaphylaxis
  • 批准号:
    10408011
  • 项目类别:
  • 资助金额:
    $54.8万
  • 财政年份:
    2020
  • 负责人:
    RAIF SALIM GEHA
  • 依托单位:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
  • 批准号:
    10265627
  • 项目类别:
  • 资助金额:
    $44.25万
  • 财政年份:
    2020
  • 负责人:
    RAIF SALIM GEHA
  • 依托单位:
Molecular and cellular mechanisms in food anaphylaxis
  • 批准号:
    10030396
  • 项目类别:
  • 资助金额:
    $54.8万
  • 财政年份:
    2020
  • 负责人:
    RAIF SALIM GEHA
  • 依托单位:
海外基金